Trial Details
TERMINATEDBasic Information
| Clinical ID | c1429 |
|---|---|
| Identifier | NCT03478956 |
| Trial Title | A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: Etrolizumab |
Participant Information
| Sponsor | Hoffmann-La Roche |
|---|---|
| City | Bruxelles |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2018-03-27 |
|---|---|
| Primary Completion Date | 2019-12-02 |
| Completion Date | 2023-09-27 |